AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC

Go back to AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC
Amgen Inc (NASDAQ: AMGN) Delayed: 362.12 +1.57 (0.44%)
Previous Close $360.55    52 Week High $176.85 
Open $362.15    52 Week Low $133.64 
Day High $362.78    P/E 54.54 
Day Low $356.87    EPS $6.64 
Volume 2,246,783